EDAIC Part I study materials
EDAIC Part I study resources

EDAIC Part I key terms

EDAIC Part I · Get comfortable with the vocabulary.

Functional residual capacity (FRC)

The volume of gas remaining in the lungs at the end of a normal passive expiration. It results from the balance between outward chest wall recoil and inward lung elastic recoil, and is the reservoir for gas exchange during apnoea.

Related: Closing capacity, Compliance, Preoxygenation
Closing capacity

The lung volume at which small airways begin to close during expiration. When it exceeds functional residual capacity, airway closure occurs during tidal breathing, causing shunt and hypoxaemia, particularly in elderly or obese patients and in the supine position.

Related: Functional residual capacity (FRC), Shunt fraction, Atelectasis
Compliance

The change in volume produced by a given change in distending pressure, expressed in millilitres per centimetre of water. Static compliance reflects lung and chest wall elasticity, while dynamic compliance also includes airway resistance during inflation.

Related: Airway resistance, Functional residual capacity (FRC), Pressure-controlled ventilation
Airway resistance

The pressure gradient required to drive a given gas flow through the airways, usually expressed in centimetres of water per litre per second. It rises with bronchoconstriction, secretions, and low lung volumes, and is largely determined by large airways.

Related: Compliance, Heliox, Flow-volume loop
Shunt fraction

The proportion of cardiac output that passes through the lungs without taking part in gas exchange, mixing deoxygenated blood with arterial blood. It is calculated from the shunt equation and is poorly responsive to supplemental oxygen when large.

Related: Closing capacity, Alveolar-arterial oxygen gradient, Atelectasis
Alveolar-arterial oxygen gradient

The difference between calculated alveolar oxygen partial pressure and measured arterial oxygen partial pressure. It widens with ventilation-perfusion mismatch, shunt, and diffusion impairment, and helps distinguish hypoxaemia due to hypoventilation from intrinsic lung disease.

Related: Shunt fraction, Hypoxaemia, Alveolar gas equation
Alveolar gas equation

A relationship estimating alveolar oxygen partial pressure from inspired oxygen pressure, arterial carbon dioxide pressure, and the respiratory quotient. It underpins calculation of the alveolar-arterial gradient and assessment of oxygenation efficiency.

Related: Alveolar-arterial oxygen gradient, Hypoxaemia
Oxygen delivery (DO2)

The total amount of oxygen transported to the tissues each minute, the product of cardiac output and arterial oxygen content. Content depends mainly on haemoglobin concentration and saturation, so anaemia and low output both reduce delivery.

Related: Oxygen consumption (VO2), Mixed venous oxygen saturation, Cardiac output
Oxygen consumption (VO2)

The volume of oxygen taken up by the body per minute, normally about 250 millilitres at rest and rising several-fold with sepsis, shivering, or exercise. When consumption exceeds delivery, anaerobic metabolism and lactic acidosis develop.

Related: Oxygen delivery (DO2), Mixed venous oxygen saturation, Lactate
Mixed venous oxygen saturation

The oxygen saturation of blood in the pulmonary artery, reflecting the balance between whole-body oxygen delivery and consumption. A low value suggests inadequate delivery or increased demand, though it can be misleading in regional ischaemia or shunting.

Related: Oxygen delivery (DO2), Oxygen consumption (VO2), Central venous oxygen saturation
Central venous oxygen saturation

Oxygen saturation sampled from the superior vena cava or right atrium, used as a surrogate for mixed venous saturation. It is usually slightly higher than true mixed venous blood because it drains the brain and kidneys, which extract less oxygen.

Related: Mixed venous oxygen saturation, Oxygen delivery (DO2)
Preoxygenation

The administration of high inspired oxygen before induction of anaesthesia to replace nitrogen in the functional residual capacity with oxygen. This creates a larger safe apnoea time before desaturation occurs during airway management.

Related: Functional residual capacity (FRC), Atelectasis, Rapid sequence induction
Atelectasis

Collapse or loss of aeration of lung tissue, commonly occurring in dependent regions during general anaesthesia and after cardiac or abdominal surgery. It contributes to shunt, reduced compliance, and postoperative pulmonary complications.

Related: Closing capacity, Preoxygenation, Positive end-expiratory pressure (PEEP)
Positive end-expiratory pressure (PEEP)

A positive pressure maintained in the airways at end-expiration during mechanical ventilation. It recruits collapsed alveoli, increases functional residual capacity, and improves oxygenation, but can reduce venous return and cause barotrauma.

Related: Atelectasis, Compliance, Auto-PEEP
Auto-PEEP

The unintentional retention of positive pressure in the alveoli at end-expiration, also called intrinsic PEEP. It arises when expiratory time is insufficient, as in asthma or high minute ventilation, and can cause hypotension and increased work of breathing.

Related: Positive end-expiratory pressure (PEEP), Dynamic hyperinflation
Dynamic hyperinflation

Progressive increase in lung volume over successive breaths when expiration is incomplete before the next breath begins. It raises intrathoracic pressure, impairs venous return, and can precipitate hypotension or cardiac arrest in severe obstructive disease.

Related: Auto-PEEP, Airway resistance
Volume-controlled ventilation

A ventilator mode delivering a set tidal volume at a set rate, with airway pressure determined by compliance and resistance. It guarantees minute ventilation but may generate high pressures if the lungs are stiff.

Related: Pressure-controlled ventilation, Compliance, Plateau pressure
Pressure-controlled ventilation

A ventilator mode delivering gas at a set inspiratory pressure for a set time, with tidal volume dependent on compliance and resistance. It produces decelerating flow and may improve distribution but requires monitoring of delivered volume.

Related: Volume-controlled ventilation, Compliance, Plateau pressure
Plateau pressure

The proximal airway pressure measured during an end-inspiratory pause, reflecting alveolar pressure when flow has ceased. It is used to estimate the risk of ventilator-induced lung injury, with values above about thirty centimetres of water considered potentially harmful.

Related: Driving pressure, Volume-controlled ventilation, Acute respiratory distress syndrome
Driving pressure

The difference between plateau pressure and applied positive end-expiratory pressure. It reflects the cyclic stretch applied to the lung per breath and is associated with mortality in acute respiratory distress syndrome, independent of tidal volume.

Related: Plateau pressure, Positive end-expiratory pressure (PEEP), Acute respiratory distress syndrome
Acute respiratory distress syndrome

An acute inflammatory lung injury causing bilateral opacities, severe hypoxaemia, and reduced compliance that cannot be fully explained by cardiac failure. Management emphasises lung-protective ventilation, prone positioning in severe cases, and treatment of the underlying cause.

Related: Driving pressure, Plateau pressure, Recruitment manoeuvre
Recruitment manoeuvre

A transient increase in airway pressure designed to reopen collapsed alveoli, often followed by adequate positive end-expiratory pressure to keep them open. It may improve oxygenation but carries risks of hypotension and barotrauma.

Related: Acute respiratory distress syndrome, Positive end-expiratory pressure (PEEP), Atelectasis
Rapid sequence induction

A technique for inducing anaesthesia in patients at risk of aspiration, using a rapidly acting induction agent followed promptly by tracheal intubation with minimal interval for positive-pressure ventilation. Cricoid pressure and preoxygenation are often included.

Related: Preoxygenation, Suxamethonium, Aspiration pneumonitis
Suxamethonium

A depolarising neuromuscular blocking agent with the fastest onset and shortest duration of the commonly used relaxants. It is used for rapid sequence induction but can cause hyperkalaemia, bradycardia, and malignant hyperthermia, and is contraindicated in burns and denervation.

Related: Rapid sequence induction, Malignant hyperthermia, Neuromuscular blockade
Neuromuscular blockade

Pharmacological paralysis produced by drugs that interfere with transmission at the motor end plate, either depolarising or non-depolarising. Depth is monitored with peripheral nerve stimulation, and residual block must be excluded before extubation.

Related: Suxamethonium, Train-of-four ratio, Neostigmine
Train-of-four ratio

The ratio of the fourth to the first evoked muscle response during four supramaximal stimuli delivered to a peripheral nerve. A ratio above 0.9 indicates adequate recovery from neuromuscular blockade before extubation.

Related: Neuromuscular blockade, Neostigmine, Postoperative residual curarisation
Neostigmine

An acetylcholinesterase inhibitor used to reverse non-depolarising neuromuscular blockade by increasing acetylcholine at the motor end plate. It is given with an antimuscarinic to prevent bradycardia and is ineffective against deep block.

Related: Train-of-four ratio, Neuromuscular blockade, Sugammadex
Sugammadex

A modified gamma-cyclodextrin that encapsulates rocuronium and vecuronium, rapidly reversing even deep neuromuscular blockade. It avoids the ceiling effect of acetylcholinesterase inhibitors but can cause anaphylaxis and bradycardia.

Related: Neostigmine, Neuromuscular blockade, Train-of-four ratio
Malignant hyperthermia

A pharmacogenetic hypermetabolic crisis triggered by volatile anaesthetics and depolarising relaxants, caused by uncontrolled calcium release in skeletal muscle. Features include rising temperature, rigidity, hypercapnia, and acidosis, treated with dantrolene and supportive care.

Related: Suxamethonium, Dantrolene, Hypercapnia
Dantrolene

The specific treatment for malignant hyperthermia, acting by inhibiting calcium release from the sarcoplasmic reticulum of skeletal muscle. It is given intravenously in repeated doses until the crisis is controlled, alongside cooling and correction of acidosis.

Related: Malignant hyperthermia
Aspiration pneumonitis

Chemical injury to the lungs caused by inhalation of gastric contents, producing bronchospasm, hypoxaemia, and pulmonary oedema within hours. Management is supportive, with airway protection, oxygen, and ventilation as required; antibiotics are reserved for infection.

Related: Rapid sequence induction, Atelectasis
Laryngospasm

Reflex closure of the vocal cords caused by stimulation of the laryngeal nerves, often during light anaesthesia, airway manipulation, or extubation. It is managed with continuous positive airway pressure, deepening anaesthesia, or small doses of a muscle relaxant.

Related: Neuromuscular blockade, Suxamethonium
Cardiac output

The volume of blood ejected by the heart each minute, the product of heart rate and stroke volume. It determines oxygen delivery and is influenced by preload, contractility, and afterload.

Related: Oxygen delivery (DO2), Stroke volume variation, Frank-Starling relationship
Stroke volume variation

The percentage change in stroke volume over the respiratory cycle during positive-pressure ventilation. A large variation suggests fluid responsiveness in patients in sinus rhythm with controlled ventilation, but it is unreliable in spontaneous breathing or arrhythmia.

Related: Cardiac output, Frank-Starling relationship, Positive end-expiratory pressure (PEEP)
Frank-Starling relationship

The observation that increasing ventricular filling (preload) increases stroke volume up to a point, after which further filling gives little additional output. It guides fluid therapy and explains why fluid responsiveness depends on where the ventricle sits on this curve.

Related: Stroke volume variation, Cardiac output
Lactate

An end product of anaerobic glucose metabolism that rises when tissue oxygen delivery is inadequate or when metabolism is altered, as in sepsis. Clearance over time is used as a marker of resuscitation response and prognosis.

Related: Oxygen consumption (VO2), Oxygen delivery (DO2), Sepsis
Sepsis

Life-threatening organ dysfunction caused by a dysregulated host response to infection. Management includes prompt antimicrobials, source control, fluid resuscitation, and vasopressors, with attention to oxygen delivery and lactate clearance.

Related: Lactate, Noradrenaline, Septic shock
Septic shock

Sepsis with persisting hypotension requiring vasopressors to maintain mean arterial pressure and a raised lactate despite adequate fluid resuscitation. It carries high mortality and reflects profound circulatory and metabolic derangement.

Related: Sepsis, Noradrenaline, Lactate
Noradrenaline

A predominantly alpha-adrenergic vasopressor used first line in septic and other vasodilatory shock to restore mean arterial pressure. It increases systemic vascular resistance with modest effects on cardiac output and is titrated to a pressure target.

Related: Septic shock, Sepsis, Mean arterial pressure